↓ Skip to main content

Monoclonal antibodies for prophylaxis and therapy of respiratory syncytial virus, SARS-CoV-2, human immunodeficiency virus, rabies and bacterial infections: an update from the World Association of…

Overview of attention for article published in Frontiers in immunology, May 2023
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (82nd percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

twitter
15 X users

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
25 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Monoclonal antibodies for prophylaxis and therapy of respiratory syncytial virus, SARS-CoV-2, human immunodeficiency virus, rabies and bacterial infections: an update from the World Association of Infectious Diseases and Immunological Disorders and the Italian Society of Antinfective Therapy
Published in
Frontiers in immunology, May 2023
DOI 10.3389/fimmu.2023.1162342
Pubmed ID
Authors

Susanna Esposito, Gayatri Amirthalingam, Matteo Bassetti, Francesco Blasi, Francesco Giuseppe De Rosa, Natasha B. Halasa, Ivan Hung, Albert Osterhaus, Tina Tan, Juan Pablo Torres, Antonio Vena, Nicola Principi

X Demographics

X Demographics

The data shown below were collected from the profiles of 15 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 25 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 2 8%
Student > Master 2 8%
Professor 2 8%
Lecturer > Senior Lecturer 1 4%
Student > Doctoral Student 1 4%
Other 3 12%
Unknown 14 56%
Readers by discipline Count As %
Unspecified 2 8%
Immunology and Microbiology 2 8%
Engineering 2 8%
Biochemistry, Genetics and Molecular Biology 1 4%
Business, Management and Accounting 1 4%
Other 4 16%
Unknown 13 52%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 June 2023.
All research outputs
#3,925,976
of 26,173,059 outputs
Outputs from Frontiers in immunology
#4,504
of 32,855 outputs
Outputs of similar age
#71,927
of 401,941 outputs
Outputs of similar age from Frontiers in immunology
#113
of 1,311 outputs
Altmetric has tracked 26,173,059 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,855 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.6. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 401,941 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 1,311 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.